Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Bacterial Vaginitis: later-stage trial registry

1 of 1 indexed Bacterial Vaginitis trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Bacterial Vaginitis: 1 US clinical trial tracked, 1 recruiting.

Bacterial Vaginitis is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Tulane University, running 1 of these trials.

Enrollment posture brief

Registry condition bacterial-vaginitis

OPEN 1 | RECR 100% | LATE 1 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Bacterial Vaginitis (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Bacterial Vaginitis

Bacterial Vaginitis lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Bacterial Vaginitis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Bacterial Vaginitis is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Top Sponsors

Named interventions

Most-linked intervention names on Bacterial Vaginitis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Secnidazole 2000 MG Drug
1 trials
Metronidazole 500 mg Drug
1 trials

US sites by state

Facility locations filed on Bacterial Vaginitis trials. A trial with sites in several states counts in each.

Louisiana 1 trials
Florida 1 trials
Alabama 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Bacterial Vaginitis page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Bacterial Vaginitis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Tulane University sponsors the most Bacterial Vaginitis trials on record, review their full trial history before evaluating a specific study. See Tulane University's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Bacterial Vaginitis condition card totals 1 registered trials; most-linked intervention Secnidazole 2000 MG; top US site state Louisiana. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.